Article R6123-92-10 of the French Public Health Code
When the holder of the surgical oncology authorisation implements a hybrid practice of surgical oncology management with the administration of a systemic cancer drug treatment intraoperatively or in the immediate aftermath of surgery, he must also be the holder of the authorisation for the systemic cancer drug treatment modality or be associated with a holder of this authorisation under the conditions set out in article R. 6123-90-1. A protocol for…